Grants
Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring and Endpoint Development (UG3/UH3 - Clinical Trial Optional) (PAR-25-170)
Sponsor
National Institutes of Health
Due Date
Multiple due dates; see announcement.